Cytokinetics CYTK PA — Operating Lease Liability
Discontinued — last reported Q4 '25
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Cytokinetics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's pa — operating lease liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cytokinetics's PA — operating lease liability?
- Cytokinetics (CYTK) reported PA — operating lease liability of $2.4M in Q4 2025.
- What does PA — operating lease liability mean?
- The total amount of money the company owes for future operating lease payments.
- How do you interpret PA — operating lease liability?
- An increase signifies higher long-term financial obligations, which may impact leverage ratios and future cash flow requirements.
- How does PA — operating lease liability compare across companies?
- Standard liability reporting for all companies with significant operating lease portfolios.